日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy

评估动态增强磁共振成像在新辅助化疗患者中鉴别 HER2 阴性、HER2 低表达和 HER2 阳性乳腺癌的价值

Hu, Yangling; Li, Meizhi; Hu, Yalan; Wang, Mengyi; Lin, Yingyu; Mao, Lijuan; Wang, Chaoyang; Shui, Yanhong; Song, Yutong; Wang, Huan; Ji, Lin; Che, Xin; Shao, Nan; Zhang, Xiaoling

Vortioxetine exhibits anti-glioblastoma activity via the PI3K-Akt signaling pathway

沃替西汀通过 PI3K-Akt 信号通路发挥抗胶质母细胞瘤活性

Huan-Qi Zhang, Dao-Ming Zhang, Zhi-Zhen Huang, Jing Cheng, Chong Zhang, Neng-Ming Lin, Yangling Li

Upregulation of CoQ shifts ferroptosis dependence from GPX4 to FSP1 in acquired radioresistance

在获得性放射抗性中,CoQ 的上调将铁死亡依赖性从 GPX4 转移到 FSP1

Xu Lin, Qingyi Zhang, Qi Li, Jun Deng, Shuying Shen, Muhu Tang, Xianghua Ye, Cong Ji, Yuhong Yang, Yuxiao Chen, Liping Zeng, Jiangang Zhao, M B N Kouwenhoven, Don Eliseo Lucero-Prisno 3rd, Junjie Huang, Yangling Li, Bo Zhang, Jian Hu

SPTBN2 suppresses ferroptosis in NSCLC cells by facilitating SLC7A11 membrane trafficking and localization

SPTBN2 通过促进 SLC7A11 膜运输和定位来抑制 NSCLC 细胞中的铁死亡

Jun Deng, Xu Lin, Jiajia Qin, Qi Li, Yingqiong Zhang, Qingyi Zhang, Cong Ji, Shuying Shen, Yangling Li, Bo Zhang, Nengming Lin

Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1

Wee1 抑制剂 PD0166285 通过 STAT1 使 TP53 突变肺鳞状细胞癌对顺铂敏感

Qi Li #, Wenjie Yang #, Qingyi Zhang #, Daoming Zhang #, Jun Deng, Binxin Chen, Ping Li, Huanqi Zhang, Yiming Jiang, Yangling Li, Bo Zhang, Nengming Lin

Targeting pancreatic stellate cells in chronic pancreatitis: Focus on therapeutic drugs and natural compounds

针对慢性胰腺炎中胰腺星状细胞的治疗:聚焦治疗药物和天然化合物

Wu, Yang; Zhang, Chun; Guo, Mei; Hu, Weikang; Qiu, Yangling; Li, Mengran; Xu, Dong; Wu, Pengfei; Sun, Jing; Shi, Run; Zhang, Zili; Jiang, Kuirong

Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china

紫杉醇、多柔比星、环磷酰胺和曲妥珠单抗与多西他赛、顺铂和曲妥珠单抗在中国乳腺癌新型辅助治疗中的成本效益分析

Xu, Qiaoping; Yuanyuan, Li; Jiejing, Zhu; Jian, Liu; Qingyu, Li; Lingya, Chen; Ying, Luo; Changchen, Shi; Yangling, Li; Wei, Yan

DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors

DYRK1A 抑制可抑制 Mcl-1 表达并使 NSCLC 细胞对 Bcl-2 抑制剂敏感

Yangling Li, Dongmei Zhou, Shuang Xu, Mingjun Rao, Zuoyan Zhang, Linwen Wu, Chong Zhang, Nengming Lin

Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells

他汀类药物抑制 KLF4 可逆转阿霉素诱导的骨肉瘤细胞转移和癌症干细胞特性

Yangling Li, Miao Xian, Bo Yang, Meidan Ying, Qiaojun He

Synthesis of AG@AgCl Core-Shell Structure Nanowires and Its Photocatalytic Oxidation of Arsenic (III) Under Visible Light

AG@AgCl核壳结构纳米线的合成及其在可见光下对砷(III)的光催化氧化

Qin, Yanyan; Cui, Yanping; Tian, Zhen; Wu, Yangling; Li, Yilian